Aryl ureas represent a new class of anti-trypanosomal agents (Q30922198)

27 June 2017

Aryl ureas represent a new class of anti-trypanosomal agents (English)

1 reference

27 June 2017

5

Cohen FE

1 reference

27 June 2017

Du X

1

1 reference

27 June 2017

Hansell E

2

1 reference

27 June 2017

Engel JC

3

1 reference

27 June 2017

Caffrey CR

4

1 reference

27 June 2017

McKerrow JH

6

1 reference

27 June 2017

1 September 2000

1 reference

27 June 2017

Chemistry and Biology

1 reference

27 June 2017

7

1 reference

27 June 2017

9

1 reference

27 June 2017

733-742

1 reference

The proteases and pathogenicity of parasitic protozoa

27 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Characterization and expression of proteases during Trypanosoma cruzi metacyclogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

American trypanosomiasis (Chagas' disease)--a tropical disease now in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Assessment of cytogenetic damage in chagasic children treated with benznidazole

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-phe-ala-CHN2.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Structure-based inhibitor design by using protein models for the development of antiparasitic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Structure-based design of parasitic protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

The crystal structure of cruzain: a therapeutic target for Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Structural determinants of specificity in the cysteine protease cruzain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Synthesis and antifungal activity of novel thiazole-containing triazole antifungals

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Studies on aromatase inhibitors. I. Synthesis and biological evaluation of 4-amino-4H-1,2,4-triazole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

An Algorithm for Subgraph Isomorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Azole endothelin antagonists. 2. Structure-activity studies

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

TESS: a geometric hashing algorithm for deriving 3D coordinate templates for searching structural databases. Application to enzyme active sites

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Analytical molecular surface calculation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

Solvent-accessible surfaces of proteins and nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2800%2900018-1

7 January 2021

10.1016/S1074-5521(00)00018-1

Identifiers

DOI

1 reference

27 June 2017

1 reference